LINCOLN, Neb. (July 19, 2018) – Today, a Nebraska law went into effect that allows terminally ill patients to bypass some Food and Drug Administration (FDA) rules that deny access to experimental treatments. Sen. Bob Hilkemann (R-Omaha) introduced Legislature Bill 117 (LB117) last year and it carried over into the 2018 session. The new law…
LINCOLN, Neb. (April 24, 2018) – Last Thursday, Nebraska Gov. Pete Ricketts signed a bill into law setting the foundation to nullify in practice some Food and Drug Administration (FDA) rules that deny access to experimental treatments by terminally ill patients. Sen. Bob Hilkemann (R-Omaha) introduced Legislature Bill 117 (LB117) last year and it carried over…
LINCOLN, Neb. (April 19, 2018) – On Wednesday, the Nebraska legislature gave final approval to a bill that would set the foundation to nullify in practice some Food and Drug Administration (FDA) rules that deny access to experimental treatments by terminally ill patients. Sen. Bob Hilkemann (R-Omaha) introduced Legislature Bill 117 (LB117) last year and…
LINCOLN, Neb. (Jan. 13, 2016) – A bill introduced in the Nebraska Senate would set the foundation to nullify in practice some Food and Drug Administration (FDA) rules that deny access to experimental treatments by terminally ill patients. Introduced by Sen. Bob Hilkemann (R-Omaha), LB117 would give terminally ill patients access to medicines not yet given final approval…